Assembly Biosciences' (ASMB) Neutral Rating Reiterated at HC

HC Wainwright reissued their neutral rating on shares of Assembly Biosciences (NASDAQ:ASMB – Free Report) in a research note issued to investors on Monday, Benzinga reports. HC Wainwright also issued estimates for Assembly Biosciences’ Q1 2024 earnings at ($2.74) EPS, Q2 2024 earnings at ($2.96) EPS, Q3 2024 earnings at ($3.29) EPS, Q4 2024 earnings […]

Related Keywords

United States , Alexander Schornstein , Assembly Bioscience , Insider Activity At Assembly Biosciences , Acuitas Investments , Marquette Asset Management , Hedge Funds Weigh In On Assembly Biosciences , Vanguard Group Inc , Assembly Biosciences Company Profile , Assembly Biosciences Inc , Geode Capital Management , Assembly Biosciences Stock , Northern Trust Corp , Securities Exchange Commission , Assembly Biosciences , News Ratings For Assembly Biosciences Daily , Free Report , Exchange Commission , Trust Corp , Asset Management , Capital Management , Get Free Report , Assembly Biosciences Daily , Nasdaq Asmb , Wasmb , Medical , 92282210 , Reiterated Rating , Hc Wainwright ,